Implant Sciences’ QS-B220 completes qualification testing and evaluation phase

Implant Sciences’ QS-B220 desktop explosives trace detection system has completed and passed testing requirements of the qualification testing and evaluation (QT&E) phase of the Transportation Security Administration’s (TSA) Explosive Trace Detection (ETD) qualification test at the Transportation Systems Integration Facility (TSIF).

The desktop explosives trace detection system has successfully completed the first step of QT&E, called Independent Testing and Evaluation (IT&E) in July 2013.

Implant Sciences president and CEO Glenn Bolduc said that the QS-B220 evaluation was a very important achievement that demonstrates the ETD technology benefits in action.

"The QS-B220 provides superior detection capabilities, a non-radioactive source, and operational and cost efficiencies that can deliver benefits at airport security checkpoints each year," Bolduc added.

"The combination of enhanced performance and operational capabilities of the QS-B220 truly define the new standard of trace detection."

Located at Ronald Reagan Washington National Airport, the facility enables TSA to test the technology in an operational airport environment, using concepts of operation, measures of performance, and measures of effectiveness.

Implant Sciences sales and marketing vice president Dr Darryl Jones said, "Successfully completing QT&E brings us another step closer to completing TSA’s Qualified Product List process, and we are confident that the QS-B220 will meet the remaining stringent testing requirements."